Segmented Barrier for Low-Power Implantable Drug Delivery
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing implantable drug delivery and biosensor devices face challenges with high power requirements for barrier removal, short device lifetimes due to immune system reactions, and incomplete drug release due to non-uniform barrier dissolution.
Innovation Solution
A low-power, chemically amplified, electrically removable barrier system using a combination of stable and spontaneously reactive materials, where a thin, inert first layer is electrochemically removed to expose a thicker, mechanically strong second layer, which can spontaneously degrade, allowing controlled drug or sensor exposure.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If a single thick barrier is used to ensure complete drug containment, then containment reliability is improved, but the power required to remove the barrier increases significantly
Solution Approach 1:
The barrier is divided into multiple thin layers (first barrier layer, second barrier layer, third barrier layer) instead of using a single thick barrier. Each layer can be removed independently or sequentially, reducing the power required for removal while maintaining complete containment when all layers are intact. The segmented structure allows the device to achieve both high containment reliability and low removal power.
Solution Approach 2:
The barrier system uses composite material structure with different barrier layers having different properties. The first barrier layer may be electrochemically removable, the second layer may be spontaneously reactive, and the third layer may provide additional containment. This composite approach allows each layer to contribute differently to containment and removal, optimizing both reliability and power consumption.
2Manufacturing precision
If electrothermal barrier removal is used to ensure complete barrier dissolution, then barrier removal completeness is improved, but power consumption increases
Solution Approach 1:
The patent replaces electrothermal (thermal) barrier removal with electrochemical dissolution or spontaneous chemical reaction. Instead of using heat to dissolve the barrier, electrochemical methods are employed where electrical current drives chemical reactions that dissolve the barrier material directly, or the barrier material is designed to spontaneously react with body fluids. This substitution dramatically reduces power consumption while maintaining complete and uniform barrier dissolution.
Solution Approach 2:
The barrier material properties are changed to enable electrochemical dissolution or spontaneous chemical reaction instead of requiring thermal decomposition. By selecting materials with appropriate electrochemical or chemical properties, the barrier can be removed completely and uniformly through chemical means rather than thermal means, reducing power consumption while ensuring complete dissolution.
3Duration of action of stationary object
If implantable devices are left in the body for extended periods to avoid repeated implantations, then device lifetime is improved, but immune system reactions increase
Solution Approach 1:
The barrier layers are designed to be removed preliminary before the device needs to be replaced. By using electrochemical or spontaneous chemical removal mechanisms, the barrier can be cleanly removed when the device lifetime expires, allowing the device to be replaced without leaving residual materials that would trigger immune reactions. This preliminary removal action enables extended device lifetime while minimizing immune response upon replacement.
4Reliability
If multiple barrier layers are used to ensure complete containment, then containment reliability is improved, but device complexity increases
Solution Approach 1:
The barrier is segmented into multiple thin layers that can be fabricated using standard thin-film deposition techniques. Each layer serves a specific function (electrochemical removal, spontaneous reaction, additional containment) and can be deposited sequentially in a single fabrication process. This segmentation approach improves containment reliability while managing complexity through modular design and standard fabrication methods.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This solution enables efficient, controlled release of drugs or biosensor interactions with minimal power consumption, extending device lifetimes and reducing immune response, while ensuring complete and uniform barrier dissolution for effective drug delivery and sensing.
Implementation Method 1
the first barrier layer, highly inert towards the environment on the external side of the barrier, which can be controllably removed at any time by an electrical signal
Implementation Method 2
a thicker, mechanically strong second layer, which can spontaneously degrade
Data Source
AI summary
An implantable device contains a drug or biosensing compound, protected from the external environment within a human body by several barriers which are broken upon activation of the device through electrothermal, chemical, and mechanical processes. The device allows accurate and repeated dosing within a human body, thus reducing the number of implantation procedures required. This device extends the lifetime of a biosensor, reducing the number of implantation procedures required.